EugeneDKwonMD

PubMed

• Low PSA radiographic disease progression on C11-choline PET.
  Mahmoud, A., Kendi, A., Ahmed, M., Thorpe, M., Johnson, G., Riaz, I., Orme, J., Kwon, E., Andrews, J., Childs, D.> ;BJUI Compass. 2024 Mar 1
• Prostate Cancer and Malignant Ascites: The Mayo Clinic Experience With a Rare and Aggressive Disease Progression.
  Ahmed M Mahmoud, Jacob J Orme, Daniel S Childs, Mohamed E Ahmed, Anne Rajkumar, Eugene D Kwon, Jack R Andrews> ;Clinical Genitourinary Cancer. 2024 Apr 1
• Early PSA decline after starting second-generation hormone therapy in the post-docetaxel setting predicts cancer-specific survival in metastatic castrate-resistant pro...
  Mohamed E Ahmed, Ahmed M Mahmoud, Vidhu B Joshi, Ajay Gopalakrishna, Raevti Bole, Rimki Haloi, A Tuba Kendi, Michael S Bold, Alan H Bryce, Robert Jeffrey Karnes, Eugen...> ;Prostate Cancer and Prostatic Diseases. 2023 Nov 7
• 1 citations
  Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis.
  Ahmed M Mahmoud, Daniel S Childs, Mohamed E Ahmed, A Tuba Kendi, Geoffrey B Johnson, Jacob J Orme, Bradley J Stish, Ryan M Phillips, Sean S Park, Brian J Davis, Jack R...> ;The Prostate. 2024 Feb 1
• 2 citations
  Coping Mechanisms for Financial Toxicity Among Patients With Metastatic Prostate Cancer: A Survey-based Assessment.
  Daniel D Joyce, Phillip J Schulte, Eugene D Kwon, Stacie B Dusetzina, Kelvin A Moses, Vidit Sharma, David F Penson, Jon C Tilburt, Stephen A Boorjian> ;The Journal of Urology. 2023 Aug 1
• 3 citations
  Addressing the need for more therapeutic options in neuroendocrine prostate cancer.
  Jayson Kemble, Eugene D Kwon, R Jeffrey Karnes> ;Expert Review of Anticancer Therapy. 2023 Feb 1
• 4 citations
  Metastasis-directed Therapy Without Androgen Deprivation Therapy in Solitary Oligorecurrent Prostate Cancer.
  Jack R Andrews, Mohamed E Ahmed, Vidit Sharma, Cameron Britton, Bradley Stish, Ryan Phillips, A Tuba Kendi, Vidhu B Joshi, Mathew K Tollefson, Stephen A Boorjian, R Je...> ;The Journal of Urology. 2022 Dec 1
• 7 citations
  Out-of-Pocket Cost Burden Associated With Contemporary Management of Advanced Prostate Cancer Among Commercially Insured Patients.
  Daniel D Joyce, Vidit Sharma, David H Jiang, Holly K Van Houten, Lindsey R Sangaralingham, Bijan J Borah, Eugene D Kwon, David F Penson, Stacie B Dusetzina, Jon C Tilb...> ;The Journal of Urology. 2022 Nov 1
• 3 citations
  Radiographic paradoxical response in metastatic castrate-resistant prostate cancer (mCRPC) managed with new generation anti-androgens: a retrospective analysis.
  Jamal Alamiri, Cameron J Britton, Mohamed E Ahmed, Jack R Andrews, Julianna L Higa, Ayca Dundar, R Jeffrey Karnes, Eugene Kwon, Val J Lowe, Ayse T Kendi, Michael S Bol...> ;The Prostate. 2022 Dec 1
• 4 citations
  Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity.
  Fabrice Lucien, Yohan Kim, Jing Qian, Jacob J Orme, Henan Zhang, Ali Arafa, Feven Abraha, Ishwor Thapa, Erik J Tryggestad, William S Harmsen, Jorgena Kosti, Hesham Ali...> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Nov 15
• 2 citations
  Prognostic role of 11C-choline PET/CT scan in patients with metastatic castrate resistant prostate cancer undergoing primary docetaxel chemotherapy.
  Masaya Jimbo, Jack R. Andrews, Mohamed E. Ahmed, Ayca Dundar, R. Jeffrey Karnes, Alan H. Bryce, Ayse Tuba Kendi, Eugene D. Kwon, Val J. Lowe, Michael S. Bold> ;The Prostate. 2021 Oct 11
• 12 citations
  Phase II Evaluation of Stereotactic Ablative Radiotherapy (SABR) and Immunity in 11C-Choline-PET/CT-Identified Oligometastatic Castration-Resistant Prostate Cancer.
  Henan Zhang, Jacob J. Orme, F. Abraha, B.J. Stish, Val J. Lowe, Fabrice Lucien, Erik J. Tryggestad, Michael S. Bold, Lance C. Pagliaro, C. Richard Choo, Debra H. Brink...> ;Clinical Cancer Research. 2021 Sep 30
• 9 citations
  Oligorecurrent prostate cancer treated with metastases-directed therapy or standard of care: a single-center experience.
  Luca Boeri, Vidit Sharma, Eugene Kwon, Bradley J. Stish, Brian J. Davis, R. Jeffrey Karnes> ;Prostate Cancer and Prostatic Diseases. 2021 Jun 1
• 4 citations
  Patient Satisfaction of Telemedicine Visits in an Advanced Prostate Cancer Clinic During the COVID-19 Pandemic
  Mohamed E. Ahmed, Jack R. Andrews, Vidhu B. Joshi, Lance A. Mynderse, Matthew K. Tollefson, R. Jeffrey Karnes, Eugene D. Kwon> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2021 May 26
• 7 citations
  11C-choline positron emission tomography/computed tomography for detection of disease relapse in patients with history of biochemically recurrent prostate cancer and p...
  Ishan Garg, Mark A. Nathan, Ann T. Packard, Eugene D. Kwon, Nicholas B. Larson, Val J. Lowe, Brian J. Davis, Rimki Haloi, Mindie L Mahon, Ajit H. Goenka> ;Journal of Cancer Research and Therapeutics. 2021 Apr 1
• 19 citations
  Patterns of Recurrence and Modes of Progression After Metastasis-Directed Therapy in Oligometastatic Castration-Sensitive Prostate Cancer.
  Matthew P. Deek, Kekoa Taparra, Dyda Dao, Luanna Chan, Ryan Phillips, R.W. Gao, Eugene D. Kwon, Curtiland Deville, Danny Y. Song, Stephen Greco, Michael A. Carducci, M...> ;International Journal of Radiation Oncology, Biology, Physics. 2021 Feb 1
• 5 citations
  Radium-223 in the Third-Line Setting in Metastatic Castration-Resistant Prostate Cancer: Impact of Concomitant Use of Enzalutamide on Overall Survival (OS) and Predict...
  Mohamed E. Ahmed, Vidhu B. Joshi, Lance C. Pagliaro, R. Jeffrey Karnes, Val J. Lowe, Matthew P. Thorpe, Eugene D. Kwon, A Tuba Kendi> ;Clinical Genitourinary Cancer. 2021 Jan 7
• 89 citations
  Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an E...
  Karim Fizazi, Charles G. Drake, Tomasz M. Beer, Eugene D. Kwon, Howard I. Scher, Winald R. Gerritsen, Alberto Bossi, Alfons J.M. van den Eertwegh, Michael Krainer, Nad...> ;European Urology. 2020 Dec 1
• 2 citations
  Adding carboplatin to chemotherapy regimens for metastatic castrate-resistant prostate cancer in postsecond generation hormone therapy setting: Impact on treatment res...
  Mohamed E. Ahmed, Jack R. Andrews, Jamal Alamiri, Julianna Higa, Rimki Haloi, Manaf Alom, Giovanni Motterle, Vidhu B. Joshi, Paras Shah, R. Jeffrey Karnes, Eugene Kwon> ;The Prostate. 2020 Oct 1
• 1 citations
  A Rare Case of Prostate-Specific Antigen-Producing Metastatic Parotid Adenocarcinoma Developing Androgen Receptor Resistance.
  Jack R. Andrews, Mohamed E. Ahmed, Giovanni Motterle, Sam T. Albadri, Rimki Haloi, R. Jeffrey Karnes, Eugene D. Kwon, Katharine A. Price> ;Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 2020 Aug 19
• 1 citations
  Salvage Radical Prostatectomy After Robot-assisted Laparoscopic Prostatectomy: Case Series
  Mohamed E. Ahmed, Giovanni Motterle, Jack R. Andrews, Marco Moschini, Eugene D. Kwon, Robert Jeffrey Karnes> ;Clinical Genitourinary Cancer. 2020 Apr 1
• 12 citations
  Systemic treatment for metastatic castrate resistant prostate cancer: Does seqence matter?
  Jack R. Andrews, Mohamed E. Ahmed, R. Jeffrey Karnes, Eugene Kwon, Alan H. Bryce> ;The Prostate. 2020 Apr 1
• 2 citations
  The role of salvage lymph node dissection in nonmetastatic castration-resistant prostate cancer: A single center experience
  Luca Boeri, Vidit Sharma, Avinash Nehra, Eugene Kwon, R. Jeffrey Karnes> ;Urologic Oncology. 2020 Feb 1
• 11 citations
  Tumor Seeding after Robot-Assisted Radical Prostatectomy: Literature Review and Experience from a Single Institution
  Giovanni Motterle, Mohamed E. Ahmed, Jack R. Andrews, Marco Moschini, Eugene D. Kwon, R. Jeffrey Karnes> ;The Journal of Urology. 2020 Mar 17
• 9 citations
  Concordance of PD‐1 and PD‐L1 (B7‐H1) in paired primary and metastatic clear cell renal cell carcinoma
  Jeanette E. Eckel-Passow, Thai H. Ho, Daniel J. Serie, John C. Cheville, R. Houston Thompson, Brian A. Costello, Haidong Dong, Eugene D. Kwon, Bradley C. Leibovich, Al...> ;Cancer Medicine. 2020 Feb 1
• Join now to see all

Journal Articles

• Stereotactic body radiation therapy in the treatment of oligometastatic prostate cancer  
  Ahmed KA, Barney BM, Davis BJ, Park SS, Kwon ED, Olivier KR, Frontiers in Oncology, 1/2/2013
• Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers (Editorial)  
  Crispen PL, Boorjian SA, Lohse CM, Leibovich BC, Kwon ED, J Urol, 5/1/2009
• T-cell coregulatory molecular expression  
  Kwon ED, Clin Cancer Res, 1/1/2009
• Inhibitors of the B7-CD28 constimulation in urologic malignancies  
  Thompson RH, Kwon ED, Allison JP, Future Med, 1/1/2009
• Carbonic anhydrase IX is not an independent predictor of outcome for patients with clear cell renal cell carcinoma  
  Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED, J Urol, 10/1/2008
• Carbonic anhydrase IX as a predictive biomarker for clear cell renal cell carcinoma (Reply)  
  Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED, J Clin Oncol, 8/20/2008
• Carbonic anhydrase IX expression in clear cell renal cell carcinomas negatively correlates with the proportion of the granular cell component (In reply)  
  Leibovich BC, Sheinin Y, Lohse CM, Thompson RH, Cheville JC, Zavada J, Kwon ED, J Clin Oncol, 8/1/2008
• Induction of a gene expression program in dendritic cells with a cross-linking IgM antibody to the co-stimulatory molecule B7-DC  
  Blocki FA, Radhakrishnan S, Van Keulen VP, Heckman KL, Ciric B, Howe CL, Rodriguez M, Kwon E, Pease LR, FASEB J, 11/1/2006
• Novel molecular chaperone, B7-H1, promising downstream target to improve kidney cancer immunotherapy  
  Thompson RH, Kwon ED, Kidney Cancer J, 1/1/2006
• Aberrant expression of costimulatory B7-H1 in clear cell renal cell carcinoma  
  Thompson RH, Gillett MD, Cheville JC, Lohse CM, Dong H, Webster WS, Krejci KG, Lobo JR, Sengupta S, Chen L, Zincke H, Blute ML, Leibovich BC, Kwon ED, The American Journal of Urology Review, 1/1/2005
• Continent jejunal reservoir dialysis for end-stage renal disease: is it possible?  
  Moore DK, Kwon EE, Donovan JF, J Endourol, 10/1/2002
• Jejunal reservoir dialysis: investigation of factors influencing ammonium trapping  
  Lavelle JP, Donovan JF Jr, Kwon ED, Stokes JB, Schedl HP, J Urol, 10/1/1994
• The use of rhein to augment fluid and electrolyte secretion in the continent jejunal reservoir  
  Hade DK, Donovan JF Jr, Kwon ED, Stokes JB, Bertholf MB, Flanigan MJ, Schedl HP, Surg Forum, 1/1/1994
• Replacement of lost renal function: Solute and coupled urea nitrogen and hydrogen ion excretion in the jejunal reservoir/urease system  
  Kwon ED, Donovan JF, Schedl HP, Williams RD, Surg Forum, 1/1/1991
• Effects of sodium deoxycholate (NaDC) on clearance of electrolytes, urea nitrogen (BUN), uric acid (UA), and creatinine (CR) from loops of the dog jejunum  
  Kwon ED, Schedl HP, Donovan JF, Lawton WJ, Lubaroff DM, Williams RD, J Urol, 1/1/1989
• Adjunct gold (198Au) therapy for localized carcinoma of the prostate  
  Kwon ED, Loening SA, Hawtrey CE, J Urol, 1/1/1989
• Adjunct gold (198Au) therapy of clinical stage C carcinoma of the prostate  
  Loening SA, Kwon ED, Hawtrey CE, J Urol, 1/1/1989
• Percutaneous transperineal placement of radioactive gold seed for treatment of localized prostatic carcinoma  
  Loening SA, Kwon ED, J Endourol, 1/1/1989
• Magnetic resonance imaging in the evaluation of prostate cancer  
  Kwon ED, Williams RD, World J Urol, 1/1/1989
• Traumatic ureteroduodenal fistula  
  Cooper CS, Kwon ED, Donovan JF Jr
• Organice osmolyte distribution and levels in the mammalian urinary bladder in diuresis and antidiuresis  
  Kwon ED, Dooley JA, Jung KY, Andrews PM, Garcia-Perez A, Burg MB
• Join now to see all

Books/Book Chapters

• Renal cell carcinoma: molecular targets and clinical applications. 
  Chapter: Restoring host antitumoral immunity: how coregulatory molecules are changing the approach to the management of renal cell carcinoma. 
  Page 367 - 403Inman BA, Frigola X, Dong H, Yang JC, Kwon EDEditors: Bukowski RM, Figlin RA, Motzer RJ.Humana Press, New York, NYEdition 2nd,2009
• Current protocols in immunology. 
  Chapter: The TRAMP mouse as a model for prostate cancer. 
  Page 1 - 23Hurwitz AA, Foster BA, Allison JP, Greenberg NM, Kwon EDEditors: Kruisbeek AM.John Wiley & Sons, Inc.2001
• Principles and practice of the biologic therapy of cancer. 
  Chapter: CTLA-4 blockade in tumor immunotherapy. 
  Page 890 - 895Allison JP, Hurwitz AA, Elsas AV, Kwon ED, Sullivan T, Foster BA, Greenberg NMEditors: Rosenberg SA.Lippincott Williams & Wilkins, Philadelphia, PAEdition 3rd,2000
• New vaccine technologies. 
  Chapter: Peptide vaccines from a technological perspective. 
  Page 214 - 226Yang D, Holt GE, Rudolf MP, Velders MP, Brandt RMP, Kwon ED, Kast WMEditors: Ellis RW.Eurekah.com, Austin, TX2000
• Textbook of operative urology. 
  Chapter: The laparoscopic varix ligation. 
  Page 156 - 163Donovan JF Jr, Kwon ED, Sandlow JEditors: Marshall FF.W.B. Saunders, Philadelphia, PA1996
• Laparoscopic urologic surgery. 
  Chapter: Laparoscopic varix ligation. 
  Page 335 - 397Kwon ED, Donovan JF JrEditors: Clayman R.Mosby Company, St. Louis, MO1996
• Principles of Med Biol. 
  Chapter: Organic osmolytes in renal medullary cells. 
  Page 807 - 832Kwon ED, Burg MBEditors: Bittar E, Bittar N.JAI Press1996
• Testis Cancer. 
  Chapter: Preservation of fertility in the testicular cancer patient: Considerations before and after cancer therapy. 
  Donovan JF Jr, Cooper C, Kwon ED, Sandlow JI, Sparks AETEditors: D Schnorr, SA Loening, L WeiBach.Blackwell Wissenschafts-Verlag Publishing Company, Berlin, Germany1995
• Alternative Therapies for the Treatment of Adenocarcinoma of the Prostate. 
  Chapter: Alternative Therapies for the Treatment of Adenocarcinoma of the Prostate. 
  Kwon ED, Loening SAEditors: H. Sommerkamp, and J. Altwein.Karger Publishing Company, Munich, Germany1989
• Genitourinary Surgery. 
  Chapter: Genitourinary Surgery. 
  Kwon ED, Williams RDEditors: M. Droller.C.V. Mosby Company, St. Louis, MO1989
• Join now to see all

Abstracts/Posters

• Pd-1 blockade enhances radiation therapy-induced abscopal effect.
  Park SS, Dong H, Zhao W, Grams MP, Liu X, Harrington SM, Furutani KM, Krco CJ, Olivier KR, Markovic SN, Kwon ED, Int J Radiat Oncol Biol Phys, 9/1/2014
• Programmed cell death 1 ligand 1 expression and association with survival in mesothelioma.
  Mansfield AS, Peikert T, Roden A, Krco C, Harrington S, Dong H, Kwon E, J Thorac Oncol, 4/1/2014
• Characterization of immune-related adverse events (iraes) in a phase 3 trial of ipilimumab (ipi) versus placebo (pbo) in post-docetaxel mcrpc.
  Beer TM, Logothetis C, Gerritsen WR, Kwon ED, Scher HI, Bossi A, van den Eertwegh AJM, Drake CG, McHenry B, Liu D, Fizazi K, J Clin Oncol, 2/1/2014
• Mcrpcresults of subset analyses on overall survival (os) from study ca184-043: ipilimumab (ipi) versus placebo (pbo) in post-docetaxel metastatic castration-resistant ...
  Drake CG, Kwon ED, Fizazi K, Bossi A, van den Eertwegh AJM, Logothetis C, Scher HI, Beer TM, McHenry B, Liu D, Gerritsen WR, J Clin Oncol, 2/1/2014
• Ca184-043: a randomized, multicenter, double-blind phase 3 trial comparing overall survival (os) in patients (pts) with post-docetaxel castration-resistant prostate ca...
  Gerritsen WR, Kwon ED, Fizazi K, Bossi A, Van den Eertwegh A, Logothetis C, Scher HI, Beer TM, McHenry MB, Gagnier P, Drake CG, Eur J Cancer, 9/1/2013
• Endogenous tumor-reactive cd8+t cells are differentiated effector cells with high expression of cd11a and pd-1 but are unable to control tumor growth.
  Gibbons R, Liu X, Harrington S, Krco C, Markovic S, Kwon E, Dong HD, J Immunol, 5/1/2013
• Immune monitoring using the predictive power of immune profiles.
  Dietz A, Gustafson MP, Lin Y, LaPlant BR, Liwski CJ, Maas ML, League SC, Bauer PR, Abraham RS, Tollefson MK, Kwon ED, Gastineau DA., Cytotherapy, 4/1/2013
• Role of stereotactic body radiation therapy in oligometastatic, hormone refractory prostate cancer.
  Ahmed K, Park SS, Kwon ED, Olivier KR, Int J Radiat Oncol Biol Phys, 11/1/2012
• Down-staging of locally advanced prostate cancer with anti-CTLA-4 monoclonal antibody prior to radical prostatectomy.
  Granberg C, Thompson RH, Quevedo JF, Karnes RJ, Frank I, Kwon ED, Blute ML, J Clin Oncol, 5/20/2009
• Association of reduced intraepithelial CD3+/regulatory T-cell ratio with poor outcome in human colon cancers.
  Sinicrope FA, Rego RL, Foster NR, Sargent DJ, Ansell SM, Kwon ED, J Clin Oncol, 5/20/2008
• Costimulatory molecule b7-h3 is overexpressed in renal angiomyolipoma.
  Sheinin Y, Boorjian SA, Crispen PL, Lohse CM, Leibovich BC, Kwon ED, Virchows Arch, 5/1/2008
• B7-h1 expression predicts tumor recurrence in patients with favorable histology Wilms' tumor.
  Routh JC, Ashley RA, Sebo TJ, Lohse CM, Husmann DA, Kramer SA, Kwon ED, J Urol, 4/1/2007
• Pediatric renal cell carcinoma: an aggressive tumor with biologic features distinct from its adult counterpart.
  Ashley RA, Routh JC, Siddiqui SA, Inman BA, Sebo TJ, Husmann DA, Kramer SA, Kwon ED, J Urol, 4/1/2007
• Cancer-specific mortality is increased by erythrocyte transfusion in patients undergoing surgery for renal cell carcinoma.
  Routh JC, Lohse CM, Frank I, Cheville JC, Blute ML, Kwon ED, Leibovich BC, J Urol, 4/1/2007
• Rare expression or mutation of C-KIT in grade 4 renal cell carcinoma with or without sarcomatoid differentiation.
  Sengupta S, Leibovich BC, Corless CL, Cheville JC, Lohse CM, Heinrich MC, Kwon ED, Zincke H, Blute ML, J Urol, 4/1/2006
• PD-1 expression by tumor infiltrating lymphocytes is associated with poor prognosis in renal cell carcinoma patients.
  Thompson RH, Dong H, Lohse CM, Cheville JC, Kwon ED, J Urol, 4/1/2006
• Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long term follow-up.
  Thompson RH, Leibovich BC, Dong H, Lohse CM, Webster WS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED, J Urol, 4/1/2006
• The immunomodulatory protein B7-H4 expression in renal cell carcinoma patients: a strong predictor of cancer progression and survival.
  Krambeck AE, Parks E, Lohse CM, Cheville JC, Dong H, Leibovich BC, Blute ML, Kwon ED, J Urol, 4/1/2006
• Complete tumor regression of established murine renal cell carcinoma following CD4+ T cell depletion and B7-H1 blockade.
  Webster WS, Dong H, Thompson RH, Sengupta S, Lohse CM, Leibovich BC, Blute ML, Kwon ED, J Urol, 4/1/2006
• 25-year outcomes of radical prostatectomy for the treatment of all stages of non-metastatic prostate cancer.
  Inman BA, Slezak JM, Kwon ED, Myers RP, Leibovich BC, Blute ML, Zincke H, J Urol, 4/1/2006
• High expression levels of survivin protein are an independent predictor of poor outcome among patients treated surgically for clear cell renal cell carcinoma.
  Parker AS, Kosari F, Lohse CM, Thompson RH, Kwon ED, Blute ML, Leibovich BC, Vastmatzis G, Cheville JC, J Urol, 4/1/2006
• Is renal sinus fat invasion the same as perinephric fat invasion for PT3A renal cell carcinoma?
  Thompson RH, Leibovich BC, Cheville JC, Webster WS, Lohse CM, Kwon ED, Frank I, Zincke H, Blute ML, J Urol, 4/1/2006
• Mononuclear cell infiltration in clear cell renal cell carcinoma independently predicts patient survival.
  Webster WS, Lohse CM, Thompson RH, Dong H, Frigola X, Dicks D, Sengupta S, Frank I, Leibovich BC, Blute ML, Cheville JC, Kwon ED, J Urol, 4/1/2006
• Percutaneous image guided cryotherapy is a minimally invasive option for select renal tumors.
  Webster WS, Farrell M, Charboneau JW, Atwell T, Callstrom MR, Kwon ED, Blute ML, Zincke H, Patterson DE, J Urol, 4/1/2006
• Association of abnormal preoperative laboratory values with survival following radical nephrectomy for clinically confined clear cell renal cell carcinoma.
  Magera JS Jr, Leibovich BC, Lohse CM, Sengupta S, Cheville JC, Zincke H, Kwon ED, Blute ML, J Urol, 4/1/2006
• Join now to see all

Lectures

• CTLA-4 Blockade: From bench to bedside. 
  Lebanon, NH, 2009; Sacramento, CA, 2009 - 5/1/2009
• T Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: Clinicopathological Correlations and association with survival. 
  Cambridge, MA - 9/1/2008
• Assessment of Pathologic Inclusion Criteria of Current Adjuvant Therapy Trials for Predicting Disease Recurrence Following Nephrectomy for Renal Cell Carcinoma. 
  Chicago, IL - 9/1/2008
• Immunomodulatory Therapies. 
  Chicago, IL - 9/1/2008
• Identification of Potential Serum Markers in Clear Cell REnal Cell Carcinoma. 
  Orlando, FL - 5/1/2008
• T Cell Coregulatory Molecule Expression in Urothelial Cell Carcinoma: A Potential Target for Therapy. 
  Orlando, FL - 5/1/2008
• Aberrant Expression of B7-H3 in Clear Cell Renal Cell Carcinoma. 
  Hollywood, FL - 10/1/2007
• IMP3 Expression Predicts Metastasis and Death in Clear Cell Renal Cell Carcinoma: An Independent Validation. 
  Hollywood, FL - 10/1/2007
• B7-H1 Expression and Lymphocytic Infiltration are Reduced in Non-Clear Cell Renal Cell Carcinoma Tumors. 
  Hollywood, FL - 10/1/2007
• Survivin and B7-H1 are Collaborative Predictors of Survival and Represent Potential Therapeutic Targets for Patients with Renal Cell Carcinoma. 
  Anaheim, CA - 5/1/2007
• Patients with PT1 Renal Cell Carcinoma who Die from Disease after Nephrectomy may have Unrecognized Renal Sinus Fat Invasion. 
  Anaheim, CA - 5/1/2007
• Tumor Vasculature Expression of B7-H3 in Renal Cell Carcinoma. 
  Anaheim, CA - 5/1/2007
• PD-L1 (B7-H1)Expression by Urothelial Carcinoma of the Bladder and BCG-Induced Granulomata: Associations with Localized Stage Progression. 
  Anaheim, CA - 5/1/2007
• B7-H1 Expression Predicts Tumor Recurrence in Patients with Favorable Histology Wilms' Tumor. 
  Anaheim, CA - 5/1/2007
• Pediatric Renal Cell Carcinoma: An Aggressive Tumor with Biologic Features Distinct from its Adult Counterpart. 
  Anaheim, CA - 5/1/2007
• Comparison of Survivin Expression by Digital Imaging Analysis and Visual Assessment Among a Cohort of Patients with Clear Cell Renal Cell Carcinoma. 
  Anaheim, CA - 5/1/2007
• B7-H1, Tumor Necrosis, Mononuclear Cell Infiltration: Mechanisms of Immune Dysfunction in Renal Cell Carcinoma. 
  Chicago, IL - 9/1/2006
• Pediatric Renal Cell Carcinoma: An Aggressive Neoplasm Distinct from its Adult Counterpart. 
  Coronado, CA - 9/1/2006
• The Immunomodulatory Protein B7-H4 Expression in Renal Cell Carcinoma Patients: A Strong Predictor of Cancer Progression and Survival. 
  Coronado, CA - 9/1/2006
• Synergistic Expression of B7-H1 and Survivin Predicts Survival for Patients with Renal Cell Carcinoma. 
  Coronado, CA - 9/1/2006
• Renal Sinus Fat Invasion is Both Important and Underreported. 
  Coronado, CA - 9/1/2006
• B7-H1 Targeted Immunotherapy of Metastatic Renal Cancer. 
  Amelia Island, FL - 8/1/2006
• Tumor Necrosis/MN Cell Infiltration: Significance & Relation to Prognosis. 
  Orlando, FL - 8/1/2006
• B7-H1: The Evolving Story (Workshop). 
  Orlando, FL - 8/1/2006
• Percutaneous Image Guided Cryotherapy is a Minimally Invasive Option for Select Renal Tumors. 
  Atlanta, GA - 5/1/2006
• Join now to see all